We are live on ! Find out more
BIOA

BioAge Labs
BIOA

83 hedge funds and large institutions have $85.6M invested in BioAge Labs in 2025 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 31 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

244% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 9

178% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 9

24% more funds holding

Funds holding: 67 → 83 (+16)

12% more capital invested

Capital invested by funds: $76.2M → $85.6M (+$9.4M)

1.22% more ownership

Funds ownership: 56.57% → 57.79% (+1.2%)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1.26M

Holders
83
Holders Change
+16
Holders Change %
+23.88%
% of All Funds
1.09%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.05%
New
25
Increased
31
Reduced
9
Closed
9
Calls
–
Puts
$1.26M
Net Calls
-$1.26M
Net Calls Change
-$496K

Top Buyers

Rank Fund Capital Flow
1
ACM
ADAR1 Capital Management
Texas
+$3.89M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$3.46M
3
BlackRock
BlackRock
New York
+$2.3M
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$1.1M
5
CF
Cantor Fitzgerald
New York
+$806K

Top Sellers

Rank Fund Capital Flow
1
SCM
Suvretta Capital Management
New York
-$5.46M
2
RCM
RA Capital Management
Massachusetts
-$3.96M
3
RI
RTW Investments
New York
-$2.96M
4
CAM
Cormorant Asset Management
Massachusetts
-$1.97M
5
HHMI
Howard Hughes Medical Institute
Maryland
-$428K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1
AH Capital Management
California
$13.4M – – –
SI
2
Sofinnova Investments
California
$9.52M – – –
CAM
3
Cormorant Asset Management
Massachusetts
$8.84M -$1.97M -488,924 -19%
ACM
4
ADAR1 Capital Management
Texas
$8M +$3.89M +966,023 +99%
TCM
5
Tang Capital Management
California
$6.61M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$6.43M +$3.46M +859,886 +123%
BlackRock
7
BlackRock
New York
$5.32M +$2.3M +571,576 +80%
O
8
OrbiMed
New York
$3.81M – – –
SCV
9
Sands Capital Ventures
Virginia
$3.25M – – –
PBPIA
10
Pivotal bioVenture Partners Investment Advisor
California
$2.7M – – –
Geode Capital Management
11
Geode Capital Management
Massachusetts
$1.87M +$691K +171,426 +61%
RM
12
Redpoint Management
California
$1.58M – – –
SL
13
Siren LLC
Connecticut
$1.58M – – –
Jacobs Levy Equity Management
14
Jacobs Levy Equity Management
New Jersey
$1.13M +$1.1M +273,452 New
CFM
15
Comprehensive Financial Management
California
$1.12M – – –
Marshall Wace
16
Marshall Wace
United Kingdom
$937K +$699K +173,388 +325%
Morgan Stanley
17
Morgan Stanley
New York
$882K +$741K +183,877 +621%
CF
18
Cantor Fitzgerald
New York
$826K +$806K +200,000 New
State Street
19
State Street
Massachusetts
$664K +$226K +56,019 +53%
Northern Trust
20
Northern Trust
Illinois
$632K +$256K +63,441 +71%
SCM
21
Stonepine Capital Management
Oregon
$624K +$407K +101,085 +202%
Charles Schwab
22
Charles Schwab
California
$497K +$122K +30,335 +34%
Citadel Advisors
23
Citadel Advisors
Florida
$453K +$442K +109,605 New
Renaissance Technologies
24
Renaissance Technologies
New York
$369K +$360K +89,296 New
Fidelity Investments
25
Fidelity Investments
Massachusetts
$320K +$21.1K +5,248 +7%
1
2 3 4

BIOA Hedge Fund Activity: Q2 2025 in Review

83 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in BioAge Labs (BIOA) for Q2 2025, worth a combined $85.6M — up 12% from $76.2M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new BIOA positions and 9 closed out — a net gain of 16 holders — while 31 added to existing stakes and 9 trimmed.

The largest buyer was ADAR1 Capital Management, adding an estimated $3.89M. The largest seller was Suvretta Capital Management, exiting entirely with an estimated $5.46M sold.

  • 83 institutional investors held BioAge Labs (BIOA) as of Q2 2025, up from 67 in Q1 2025.
  • Funds reported $85.6M of BioAge Labs stock for Q2 2025, up 12% quarter-over-quarter.
  • 25 funds opened new BioAge Labs positions in Q2 2025 and 9 closed out, a net change of +16 holders.
  • The largest BioAge Labs buyer in Q2 2025 was ADAR1 Capital Management, an estimated $3.89M added.
  • The largest BioAge Labs seller in Q2 2025 was Suvretta Capital Management, an estimated $5.46M sold.

Based on aggregated 13F filings for Q2 2025.